KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) Gross Margin (2016 - 2025)

Astrana Health's Gross Margin history spans 16 years, with the latest figure at 10.17% for Q3 2025.

  • For Q3 2025, Gross Margin fell 519.0% year-over-year to 10.17%; the TTM value through Sep 2025 reached 10.25%, down 484.0%, while the annual FY2024 figure was 13.34%, 216.0% down from the prior year.
  • Gross Margin for Q3 2025 was 10.17% at Astrana Health, down from 11.91% in the prior quarter.
  • Across five years, Gross Margin topped out at 35.07% in Q3 2021 and bottomed at 7.59% in Q4 2024.
  • The 5-year median for Gross Margin is 15.11% (2024), against an average of 16.34%.
  • The largest annual shift saw Gross Margin skyrocketed 747bps in 2021 before it plummeted -1102bps in 2022.
  • A 5-year view of Gross Margin shows it stood at 11.92% in 2021, then grew by 17bps to 13.97% in 2022, then dropped by -21bps to 11.04% in 2023, then crashed by -31bps to 7.59% in 2024, then skyrocketed by 34bps to 10.17% in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Gross Margin are 10.17% (Q3 2025), 11.91% (Q2 2025), and 11.5% (Q1 2025).